These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 276621)

  • 61. Pleiotropic drug resistance in hepatocytes induced by carcinogens administered to rats.
    Carr BI
    Cancer Res; 1987 Nov; 47(21):5577-83. PubMed ID: 2889526
    [TBL] [Abstract][Full Text] [Related]  

  • 62. High susceptibility of specific inbred colonies of rats to n-2-fluorenylacetamide-induced hepatocarcinogenesis.
    Ohmori T; Kondo M; Tabei R
    Gan; 1983 Dec; 74(6):822-8. PubMed ID: 6667833
    [TBL] [Abstract][Full Text] [Related]  

  • 63. NTP Toxicology and Carcinogenesis Studies of Methyleugenol (CAS NO. 93-15-2) in F344/N Rats and B6C3F1 Mice (Gavage Studies).
    National Toxicology Program
    Natl Toxicol Program Tech Rep Ser; 2000 Jul; 491():1-412. PubMed ID: 12563349
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Biochemical microanalysis of glycogen content and glucose-6-phosphate dehydrogenase activity in focal lesions of the rat liver induced by N-nitrosomorpholine.
    Klimek F; Mayer D; Bannasch P
    Carcinogenesis; 1984 Feb; 5(2):265-8. PubMed ID: 6697443
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Altered and distorted DNA from a premalignant liver lesion induced by 2-fluorenylacetamide.
    Epstein SM; Benedetti EL; Shinozuka H; Bartus B; Farber E
    Chem Biol Interact; 1969 Oct; 1(1):113-24. PubMed ID: 5407051
    [No Abstract]   [Full Text] [Related]  

  • 66. [Hyperplastic foci in chemical carcinogenesis].
    Rubenchik BL; Romanenko AM
    Tsitologiia; 1976 Sep; 18(9):1104-10. PubMed ID: 189470
    [TBL] [Abstract][Full Text] [Related]  

  • 67. RNA synthesis and RNA polymerase activity in hepatic nuclei isolated from rats fed the carcinogen 2-acetylaminofluorene.
    Adams MP; Goodman JI
    Biochem Biophys Res Commun; 1976 Feb; 68(3):850-7. PubMed ID: 1259733
    [No Abstract]   [Full Text] [Related]  

  • 68. Absence of stainable iron from preneoplastic and neoplastic lesions in rat liver with 8-hydroxyquinoline-induced siderosis.
    Williams GM; Yamamoto RS
    J Natl Cancer Inst; 1972 Sep; 49(3):685-92. PubMed ID: 4647491
    [No Abstract]   [Full Text] [Related]  

  • 69. Decreased fidelity of DNA polymerase activity during N-2-fluorenylacetamide hepatocarcinogenesis.
    Chan JY; Becker FF
    Proc Natl Acad Sci U S A; 1979 Feb; 76(2):814-8. PubMed ID: 284402
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Induction of liver preneoplastic foci in F344 rats subjected to 28-day oral administration of diheptyl phthalate and its in vivo genotoxic potential.
    Jin M; Dewa Y; Kawai M; Nishimura J; Saegusa Y; Kemmochi S; Harada T; Shibutani M; Mitsumori K
    Toxicology; 2009 Oct; 264(1-2):16-25. PubMed ID: 19643158
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Some conclusions derived from a liver model for carcinogenesis.
    Cameron R; Farber E
    Natl Cancer Inst Monogr; 1981 Dec; (58):49-53. PubMed ID: 7341983
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Inhibitory effects of polyprenoic acid (E-5166) on N-2-fluorenylacetamide-initiated hepatocarcinogenesis in rats.
    Shima H; Kuniyasu T; Sugie S; Tanaka T; Mori H; Takahashi M; Muto Y
    Jpn J Cancer Res; 1986 Apr; 77(4):351-5. PubMed ID: 3084425
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Enhancing effect of inducers of liver microsomal enzymes on induction of hyperplastic liver nodules by N-2-fluorenylacetamide in rats.
    Tatematsu M; Nakanishi K; Murasaki G; Miyata Y; Hirose M; Ito N
    J Natl Cancer Inst; 1979 Dec; 63(6):1411-6. PubMed ID: 117197
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Effects of carbon tetrachloride and azathioprine on diethylnitrosamine and N-2-fluorenylacetamide-induced hyperplastic liver nodule and hepatocellular carcinoma.
    Sakata T
    Acta Med Okayama; 1984 Dec; 38(6):511-24. PubMed ID: 6524446
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Influence of the vitamin D status on the early hepatic response to carcinogen exposure in rats.
    He RK; Gascon-Barré M
    J Pharmacol Exp Ther; 1997 Apr; 281(1):464-9. PubMed ID: 9103532
    [TBL] [Abstract][Full Text] [Related]  

  • 76. The slow induction of resistant hepatocytes during initiation of hepatocarcinogenesis by the nongenotoxic carcinogen clofibrate.
    Nagai MK; Farber E
    Exp Mol Pathol; 1999 Dec; 67(3):144-9. PubMed ID: 10600397
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Early changes in the fine structure of rat hepatocytes, induced by the non-carcinogen 4-acetylaminofluorene.
    Flaks B
    Chem Biol Interact; 1972 Jul; 5(2):127-37. PubMed ID: 5041564
    [No Abstract]   [Full Text] [Related]  

  • 78. Inhibitory effect of reserpine on N-2-fluorenylacetamide-induced hepatocarcinogenesis in rats.
    Sugie S; Tanaka T; Kuniyasu T; Mori H
    Toxicol Lett; 1987 Jul; 37(2):115-9. PubMed ID: 3603587
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Initiation of focal hyperplastic hepatic lesions by transplacental administration of ethylnitrosourea in rats of F1 generation, and no transmission of the effect to F2 and F3 generations.
    Ogawa K; Yokokawa K; Tomoyori T; Narasaki M
    Int J Cancer; 1983 Jun; 31(6):775-7. PubMed ID: 6862686
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Glycogen phosphorylase hyperactive foci of altered hepatocytes in aged rats.
    Enzmann H; Zerban H; Löser E; Bannasch P
    Virchows Arch B Cell Pathol Incl Mol Pathol; 1992; 62(1):3-8. PubMed ID: 1352073
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.